GLOD4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.678020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.489800E-01
Normal-vs-Stage2
9.683800E-02
Normal-vs-Stage3
8.919200E-03
Normal-vs-Stage4
9.784500E-02
Stage1-vs-Stage2
3.727800E-01
Stage1-vs-Stage3
3.889700E-02
Stage1-vs-Stage4
4.254400E-01
Stage2-vs-Stage3
4.544100E-02
Stage2-vs-Stage4
8.124800E-01
Stage3-vs-Stage4
1.519230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.701810E-01
Normal-vs-AfricanAmerican
2.049400E-01
Normal-vs-Asian
5.951900E-02
Caucasian-vs-AfricanAmerican
4.006400E-01
Caucasian-vs-Asian
4.785800E-01
AfricanAmerican-vs-Asian
1.380790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.409010E-01
Normal-vs-Female
2.015800E-01
Male-vs-Female
3.503400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.618400E-02
Normal-vs-Age(41-60Yrs)
3.516400E-01
Normal-vs-Age(61-80Yrs)
8.623900E-02
Normal-vs-Age(81-100Yrs)
4.385000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.267600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.938800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.994200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.999100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.464600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.398150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.106400E-02
Normal-vs-Daily Drinker
1.429440E-01
Normal-vs-Weekly Drinker
1.442810E-01
Normal-vs-Occasional Drinker
5.377800E-01
Normal-vs-Social Drinker
4.412600E-01
Non Drinker-vs-Daily Drinker
9.421400E-01
Non Drinker-vs-Weekly Drinker
9.716600E-01
Non Drinker-vs-Occasional Drinker
2.364100E-02
Non Drinker-vs-Social Drinker
1.348790E-01
Daily Drinker-vs-Weekly Drinker
9.809200E-01
Daily Drinker-vs-Occasional Drinker
7.076300E-02
Daily Drinker-vs-Social Drinker
2.275800E-01
Weekly Drinker-vs-Occasional Drinker
1.023240E-01
Weekly Drinker-vs-Social Drinker
2.809800E-01
Occasional Drinker-vs-Social Drinker
6.594600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.781200E-01
Normal-vs-Grade 2
8.796400E-01
Normal-vs-Grade 3
8.251800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.854100E-02
Grade 1-vs-Grade 3
1.921350E-01
Grade 1-vs-Grade 4
3.781200E-01
Grade 2-vs-Grade 3
1.565360E-01
Grade 2-vs-Grade 4
8.796400E-01
Grade 3-vs-Grade 4
8.251800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.349900E-02
Normal-vs-NonDiabetic
2.069600E-01
Diabetic-vs-NonDiabetic
9.580000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.213900E-02
Normal-vs-NoPancreatitis
1.443020E-01
Pancreatitis-vs-NoPancreatitis
6.573800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.735600E-01
Normal-vs-N1
1.060600E-01
N0-vs-N1
1.670220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.011700E-02
Normal-vs-TP53-NonMutant
4.980000E-01
TP53-Mutant-vs-TP53-NonMutant
1.540040E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
